Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resmed Inc’s Director, Peter Farrell, is set to sell 2,000 shares of common stock with an estimated market value of $500,000 on the NYSE. This move comes after Farrell’s recent sales totaling 4,000 shares over the past few months, reflecting his ongoing strategy to manage his stock holdings. Investors may want to watch how these transactions impact Resmed’s stock performance in the coming months.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.